Asthma control and COPD symptom burden: results from a multi-country observational study (SPRINT) in patients using fixed dose combination (FDC) inhalers
N. Roche (Paris, France), V. Plaza (Barcelona, Spain), V. Backer (Copenhagen, Denmark), J. Van Der Palen (Enschede, Netherlands), I. Cerveri (Pavia, Italy), C. Gonzalez (Valencia, Spain), G. Safioti (Amsterdam, Netherlands), I. Scheepstra (Amsterdam, Netherlands), O. Patino (Amsterdam, Netherlands), D. Singh (Manchester, United Kingdom)
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Roche (Paris, France), V. Plaza (Barcelona, Spain), V. Backer (Copenhagen, Denmark), J. Van Der Palen (Enschede, Netherlands), I. Cerveri (Pavia, Italy), C. Gonzalez (Valencia, Spain), G. Safioti (Amsterdam, Netherlands), I. Scheepstra (Amsterdam, Netherlands), O. Patino (Amsterdam, Netherlands), D. Singh (Manchester, United Kingdom). Asthma control and COPD symptom burden: results from a multi-country observational study (SPRINT) in patients using fixed dose combination (FDC) inhalers. 1006
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: